Silver Lake Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$460K Buy
5,402
+27
+0.5% +$2.41K 0.18% 81
2025
Q4
$425K Buy
5,375
+32
+0.6% +$2.51K 0.16% 81
2025
Q3
$427K Sell
5,343
-374
-7% -$31.9K 0.17% 77
2025
Q2
$520K Buy
5,717
+27
+0.5% +$2.46K 0.22% 76
2025
Q1
$533K Sell
5,690
-493
-8% -$44.1K 0.23% 72
2024
Q4
$562K Buy
6,183
+31
+0.5% +$2.96K 0.25% 70
2024
Q3
$639K Sell
6,152
-555
-8% -$56.6K 0.26% 69
2024
Q2
$651K Buy
6,707
+464
+7% +$42.8K 0.29% 64
2024
Q1
$562K Buy
+6,243
New +$529K 0.25% 66
2023
Q3
Sell
-7,256
Closed -$559K 61
2023
Q2
$559K Buy
7,256
+28
+0.4% +$2.17K 0.3% 63
2023
Q1
$543K Buy
+7,228
New +$537K 0.3% 61
2022
Q4
Sell
-8,041
Closed -$565K 65
2022
Q3
$565K Buy
8,041
+27
+0.3% +$2.12K 0.33% 62
2022
Q2
$642K Buy
8,014
+29
+0.4% +$2.27K 0.35% 61
2022
Q1
$606K Buy
7,985
+27
+0.3% +$2.14K 0.29% 65
2021
Q4
$679K Buy
7,958
+27
+0.3% +$2.11K 0.31% 65
2021
Q3
$599K Buy
7,931
+26
+0.3% +$2.06K 0.3% 69
2021
Q2
$628K Sell
7,905
-414
-5% -$33.9K 0.3% 67
2021
Q1
$656K Sell
8,319
-645
-7% -$50.6K 0.33% 65
2020
Q4
$767K Buy
8,964
+19
+0.2% +$1.57K 0.42% 62
2020
Q3
$690K Sell
8,945
-1,445
-14% -$110K 0.42% 60
2020
Q2
$761K Sell
10,390
-168
-2% -$11.9K 0.49% 56
2020
Q1
$701K Buy
10,558
+27
+0.3% +$1.9K 0.52% 54
2019
Q4
$725K Sell
10,531
-2,007
-16% -$137K 0.44% 56
2019
Q3
$922K Buy
12,538
+32
+0.3% +$2.32K 0.6% 50
2019
Q2
$896K Buy
12,506
+35
+0.3% +$2.48K 0.59% 50
2019
Q1
$855K Sell
12,471
-1,051
-8% -$67.9K 0.58% 49
2018
Q4
$805K Buy
13,522
+41
+0.3% +$2.56K 0.6% 49
2018
Q3
$903K Buy
13,481
+6
+0% +$400 0.55% 58
2018
Q2
$999K Buy
13,475
+75
+0.6% +$4.91K 0.8% 43
2018
Q1
$961K Sell
13,400
-83
-0.6% -$5.97K 0.71% 48
2017
Q4
$1.02M Buy
13,483
+34
+0.3% +$2.48K 0.72% 46
2017
Q3
$980K Sell
13,449
-26
-0.2% -$1.87K 0.75% 44
2017
Q2
$999K Buy
13,475
+31
+0.2% +$2.3K 0.74% 45
2017
Q1
$984K Sell
13,444
-1,226
-8% -$85.8K 0.74% 46
2016
Q4
$960K Sell
14,670
-703
-5% -$48.2K 0.74% 45
2016
Q3
$1.14M Sell
15,373
-38
-0.2% -$2.81K 0.85% 44
2016
Q2
$1.13M Buy
15,411
+37
+0.2% +$2.63K 0.84% 43
2016
Q1
$1.09M Sell
15,374
-33
-0.2% -$2.2K 0.92% 40
2015
Q4
$1.03M Buy
15,407
+66
+0.4% +$4.39K 0.92% 40
2015
Q3
$974K Sell
15,341
-435
-3% -$28.4K 0.88% 44
2015
Q2
$1.03M Buy
15,776
+794
+5% +$53.9K 0.84% 43
2015
Q1
$1.04M Sell
14,982
-1,662
-10% -$115K 0.84% 43
2014
Q4
$1.15M Sell
16,644
-210
-1% -$14.2K 0.94% 43
2014
Q3
$1.1M Buy
16,854
+173
+1% +$11.4K 0.9% 46
2014
Q2
$1.14M Sell
16,681
-163
-1% -$10.9K 0.95% 44
2014
Q1
$1.09M Sell
16,844
-1,173
-7% -$73.9K 0.98% 45
2013
Q4
$1.18M Buy
+18,017
New +$1.15M 1% 45

Other funds holding CL

Silver Lake Advisory's CL Position: Q1 2026 in Review

Silver Lake Advisory increased its Colgate-Palmolive (CL) stake by 0.5% in Q1 2026, buying an estimated $2.41K and bringing the position to 5,402 shares worth $460K. The position accounts for 0.18% of the portfolio, ranked #81.

Silver Lake Advisory first reported a position in CL in Q4 2013 and has held it in 47 quarters since. The position peaked at $1.18M in Q4 2013. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Silver Lake Advisory held 5,402 shares of Colgate-Palmolive worth $460K as of Q1 2026.
  • Silver Lake Advisory bought 27 Colgate-Palmolive shares in Q1 2026, an estimated $2.41K.
  • Colgate-Palmolive made up 0.18% of Silver Lake Advisory's portfolio in Q1 2026, its #81 holding.
  • Silver Lake Advisory first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 47 quarters since.
  • Silver Lake Advisory's Colgate-Palmolive position peaked at $1.18M in Q4 2013.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Silver Lake Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.